Wuling Zhu
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 20
- CAR-T cell therapy research 12
- Lymphatic System and Diseases 4
-
- Angiogenesis and VEGF in Cancer 7
- Genomics and Phylogenetic Studies 4
- Co-authors
- Lingtong Zhi (16 shared papers)Huiyong Zhang (12 shared papers)Changjiang Guo (10 shared papers)Zhiyuan Niu (15 shared papers)Han Chen (3 shared papers)Mingfeng Li (6 shared papers)Meichen Yin (5 shared papers)Dongliang Liu (1 shared paper)
- Journals
- Molecular Immunology (6 papers)INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (4 papers)Biochemical and Biophysical Research Communications (4 papers)Journal of Biotechnology (1 paper)BMC Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Wuling Zhu
35 papers receiving 493 citations
Peers
Comparison fields: 5 of 72
- Immunology 266
- Oncology 279
- Hepatology 23
- Molecular Biology 179
- Cancer Research 39
Countries citing papers authored by Wuling Zhu
This map shows the geographic impact of Wuling Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wuling Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wuling Zhu more than expected).
Fields of papers citing papers by Wuling Zhu
This network shows the impact of papers produced by Wuling Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wuling Zhu. The network helps show where Wuling Zhu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wuling Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 85 | |
| 2 | 2020 | 85 | |
| 3 | Abnormal expression of fibrinogen gamma (FGG) and plasma level of fibrinogen in patients with hepatocellular carcinoma. | 2009 | 47 |
| 4 | 2022 | 43 | |
| 5 | 2019 | 36 | |
| 6 | Messenger RNA expression of translationally controlled tumor protein (TCTP) in liver regeneration and cancer. | 2008 | 32 |
| 7 | 2016 | 25 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 19 | |
| 10 | 2017 | 11 | |
| 11 | 2016 | 10 | |
| 12 | 2019 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2025 | 5 | |
| 18 | 2024 | 5 | |
| 19 | 2020 | 4 | |
| 20 | 2023 | 4 |
About Wuling Zhu
Wuling Zhu is a scholar working on Oncology, Molecular Biology, Immunology, Ecology and Cancer Research, having authored 38 papers that have together received 498 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (12 papers), Angiogenesis and VEGF in Cancer (7 papers), Immunotherapy and Immune Responses (5 papers), Lymphatic System and Diseases (4 papers), Genomics and Phylogenetic Studies (4 papers), T-cell and B-cell Immunology (4 papers) and Microbial Community Ecology and Physiology (4 papers). The work is most often cited by research in Immunology (266 citations), Oncology (279 citations), Hepatology (23 citations), Molecular Biology (179 citations) and Cancer Research (39 citations). Wuling Zhu has collaborated with scholars based in China. Frequent co-authors include Lingtong Zhi, Huiyong Zhang, Changjiang Guo, Zhiyuan Niu, Han Chen, Mingfeng Li, Meichen Yin, Dongliang Liu, Ping Lu and Wei Chun Chang. Their work appears in journals such as Molecular Immunology, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, Biochemical and Biophysical Research Communications, Journal of Biotechnology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.